News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Nuon Therapeutics Inc. Announces Data Demonstrating Uric Acid Lowering Activity of Tranilast to Be Presented at EULAR 2010


6/3/2010 11:58:31 AM

SAN MATEO, Calif.--(BUSINESS WIRE)--Nuon Therapeutics, Inc., a privately held, clinical stage biopharmaceutical company, announced today that two scientific abstracts on the activity of tranilast against key components of gout – high serum uric acid levels and monosodium urate crystal-induced inflammation – have been accepted for The European League Against Rheumatism (EULAR) 2010 Annual European Congress of Rheumatology, to be held in Rome, Italy, June 16-19, 2010.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES